The Future of Below-The-Knee Treatment: A Look at CLI Guidelines, Clinical Trials and Outcomes
Moderator & Panelist:
Robert Beasley, MD
Palm Vascular Centers, Miami Beach, FL
Bret N. Wiechmann, MD, FSIR, FAHA, FSVM
Vascular & Interventional Physicians
Michael Lichtenberg, MD
Vascular Center Arnsberg, Germany
Daniel van den Heuvel
Saint Antonius Hospital, Nieuwegein, The Netherlands
Provided by HMP Education, an HMP Global Company.
For questions regarding this educational activity, or to cancel your account, please call 609-371-1137 or email firstname.lastname@example.org.
This activity is designed for Interventional Radiologists, Vascular Surgeons, Interventional Cardiologist, Nurses, Podiatrists, and Wound care Physicians.
After participating in this activity, learners should be better able to:
- Understand the current global guidelines for CLI treatment and apply them to practice
- Identify the importance of wound healing as an outcome in CLI clinical trials
- Recognize current and future below-the-knee treatment options for CLI patients.
To be eligible for credit, participants must complete the online activity and the evaluation. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Release Date: September 8, 2023
Expiration Date: September 8, 2024
Estimated Time to Complete: 1 hour
There is no fee associated with this activity.
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please visit the accreditation page for full accreditation details, including credit types and totals, for this activity.
HMP Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
International Credit Recognition
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside Canada that are developed by a university, academy, hospital, specialty society, or college as accredited group learning activities.
Bilateral reciprocal accreditation agreements exist between the Canadian Medical Association and the American Medical Association and the American Academy of Family Physicians.
The following Countries and Regions have reciprocity with the AMA/ACCME:
- Bavarian Chamber of Physicians (Germany)
- Bulgarian Union of Scientific Medical Societies (Bulgaria)
- Canadian Medical Association (Canada)
- Federation of Royal Colleges of Physicians (UK)
- French National Medical Council (France)
- Italian Federation of Scientific Medical Societies (Italy)
- National CME Commission of the Italian Ministry of Health (Italy)
- Royal College of Physicians and Surgeons of Canada (Canada)
- Spanish Accreditation Council for CME (Spain)
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 1 AAPA Category 1 credit. Approval valid until September 8, 2024. PAs should claim only credit commensurate with the extent of their participation.
This continuing nursing education live activity awards 1 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
This enduring activity has been planned and implemented in accordance with the standards and requirements for approval of providers of continuing education in podiatric medicine by HMP Education. HMP Education is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. HMP Education has approved this activity for 1 continuing education contact hours.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at accreditation@HMPglobal.com or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.
USE OF PROPRIETARY NAMES
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither HMP Education nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Education or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
The faculty has reported the following:
Robert E. Beasley, MD, FSIR, FSCAI - has nothing to disclose.
Bret N. Wiechmann, MD, FSIR, FAHA, FSVM - AngioDynamics: Consultant (Ongoing)|BD: Advisory Board (Ongoing)|Boston Scientific Corporation: Advisory Board (Ongoing)|Boston Scientific Corporation: Consultant (Ongoing)
Michael Lichtenberg, MD - has nothing to disclose.
Daniel van den Heuvel, MD – to be disclosed prior to presentation.
Jos C. van den Berg, MD, PhD
Professor of Radiology
University of Bern
Head of Interventional Radiology
Ospedale Regionale di Lugano, sede Civico
The planning committee is comprised of: George Adams, MD, MHS, MBA, FACC, FSCAI; Marianne Brodmann, MD; Yolanda Bryce, MD; Thomas Davis, MD; Anahita Dua, MD; Lawrence A. Garcia, MD; Carmen Heaney, RN, BSN, CCRC; Fadi Saab, MD, FACC, FSCAI; Lee Ruotsi,MD; Eric Scott, MD; Jos C. van den Berg, MD, PhD; Craig Walker, MD; Thomas Zeller, MD; and MaryEllen Fama, Liz Minor, Samantha Joy, Andrea Zimmerman EdD, Walter Anacarrow, and Kathy Edwards, HMP Education.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
For questions regarding this educational activity, please call 609.371.1137.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609.371.1137.
The following companies have provided educational grants in support of this activity:
Micro Medical Solutions